This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 1999;282:2201.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A new imaging test that shows whether blood flow to the heart is compromised may help emergency physicians confirm or rule out myocardial infarction in patients who present with chest pain but who have a normal or nondiagnostic electrocardiogram, researchers reported at the American Heart Association's annual meeting last month.

The $4.4-million multicenter ERASE Chest Pain Trial was funded by the Agency for Health Care Policy and Research and led by researchers from New England Medical Center and Tufts University School of Medicine in Boston. The study is the first prospective trial testing whether cardiac imaging using sestamibi (a radionuclide tracer) could help physicians determine whether patients with suspected acute cardiac ischemia have normal cardiac blood flow and may safely be sent home rather than admitted to the hospital.

In the study, 2456 patients were randomized during 20 months to receive either a sestamibi scan as part . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?